GLP-1 (glucagon-like peptide-1) is a hormone made in the intestines that helps regulate appetite and glucose levels
Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice
Further, while personal anecdotes offer a snapshot of an individual's experience, they arent good indicators of potential long-term effects, rare side effects, or whether similar results would occur in a broader population
GLP-1 Medications and ADHD: What Emerging Research Means for Brain Optimization Feb 15 4 min read Have you noticed more conversations linking weight-loss medications with focus and impulse control
Regarding safety issues, gastrointestinal side effects, including nausea, vomiting, and diarrhea, seemed to be the most frequent adverse events in the GLP-1RAs treatment group
Most users start noticing skin brightening within 4 to 12 weeks, depending on the dosage, skin type, and consistency
